Jana Snehasis, Paliwal Jyoti
Metabolism and Pharmacokinetics Division, Ranbaxy Research Laboratories, Plot-20, Sector-18, Udyog Vihar, Industrial Area, Gurgaon, Haryana -122015, India.
Curr Protein Pept Sci. 2007 Dec;8(6):619-28. doi: 10.2174/138920307783018668.
The human liver cytochromes P450 (CYP P450s) are superfamily of hemoproteins responsible for catalyzing the oxidative metabolism of drugs and xenobiotics entering human body. Drug-drug/xenobiotic interactions are a major cause of therapeutic failures and adverse events. The concomitant administration of inducers with other drugs that are metabolized by CYP450 can result in their altered metabolism in the gastrointestinal tract and/ or liver. The clinical importance of such interactions includes auto induction leading to suboptimal or failed treatment. It is a major concern for the drug companies while developing new drugs. The present understanding of the mechanisms of induction of CYP P450s enzymes and their regulation has made considerable progress during last few years. However there are still gaps in our understanding on molecular aspects of CYP enzymes. Therefore, it remains the subject of intense scientific research to ascertain their in vivo function, and also better understand how the expression of CYP enzymes is regulated at the molecular level. This review analyzes and presents recent findings and concepts on xenosensors and their target genes. Emphasis is given to the molecular mechanisms and signaling pathways of CYP P450 mediated induction by xenobiotics and their potential for drug-drug interactions.
人类肝脏细胞色素P450(CYP P450)是一类血红素蛋白超家族,负责催化进入人体的药物和外源性物质的氧化代谢。药物-药物/外源性物质相互作用是治疗失败和不良事件的主要原因。诱导剂与其他经CYP450代谢的药物同时给药,可导致它们在胃肠道和/或肝脏中的代谢发生改变。此类相互作用的临床重要性包括自身诱导导致治疗效果欠佳或治疗失败。这是制药公司在开发新药时主要关注的问题。在过去几年中,目前对CYP P450酶诱导机制及其调控的理解取得了相当大的进展。然而,我们对CYP酶分子层面的理解仍存在差距。因此,确定它们在体内的功能以及更好地理解CYP酶在分子水平上是如何被调控的,仍然是深入科学研究的课题。本综述分析并介绍了关于异源物传感器及其靶基因的最新发现和概念。重点是CYP P450介导的外源性物质诱导的分子机制和信号通路,以及它们在药物-药物相互作用中的可能性。